Core Laboratories N.V. (CLB) Misses Q3 EPS by 9c; Guides Q4 EPS, Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
HSBC Upgrades Core Laboratories (CLB) to Overweight
October 19, 2012 1:17 PM EDTHSBC upgraded Core Laboratories (NYSE: CLB) from Neutral to Overweight with a price target of $128.00 (from $129.00).
For an analyst ratings summary and ratings history on Core Laboratories click here. For more ratings news on... More
